Clinical Pediatric Emergency Medicine
Volume 8, Issue 2 , Pages 87-95 , June 2007

Review of Asthma: Pathophysiology and Current Treatment Options

  • Jeffrey F. Linzer Sr, MD

      Affiliations

    • Corresponding Author InformationReprint requests and correspondence: Jeffrey Linzer Sr, MD, FAAP, FACEP, Emergency Pediatric Group, Children's Healthcare of Atlanta at Egleston, 1605 Clifton Rd NE, Atlanta, GA 30322.

References 

  1. Akinbami L. The state of childhood asthma, United States, 1980-2005. Advance data from vital and health statistics; no 381 Hyattsville (MD): National Center for Health Statistics; 2006;
  2. Busse WW, O'Bryne PM, Holgate ST. Asthma pathogenesis. In:  Adkinson NF,  Yunginger JW,  Busse WW, et al. editor. Adkinson: Middleton's allergy: principles and practice. 6th ed.. Philadelphia: CV Mosby; 2006;[Chapter 66]
  3. Durham SR, Till SJ, Corrigan CJ. T lymphocytes in asthma: bronchial versus peripheral responses. J Allergy Clin Immunol. 2000;106:221–226
  4. Holgate ST, Davies DE, Lackie PM, et al. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol. 2000;105:193–204
  5. Bradding P, Freezer NJ, Sheffer AL, et al. Asthma. In:  Frank MM,  Austen KF,  Claman HN, et al. editor. Samter's immunologic diseases. 5th ed.. Boston: Little, Brown and Company; 1995;p. 1293–1327
  6. Lagerstrand L, Bylin G, Hedenstierna G, et al. Relationships among gas exchange, spirometry and symptoms in asthma. Eur J Med. 1992;1:145–152
  7. National Heart, Lung, and Blood Institute , National Institutes of Health . Expert panel report 2: guidelines for the diagnosis and management of asthma. 1997;NIH Publication No. 97-4051, Bethesda, MD
  8. Ferrer A, Roca J, Wagner PD, et al. Airway obstruction and ventilation-perfusion relationships in acute severe asthma. Am Rev Respir Dis. 1993;147:579–584
  9. Ben-Ziv Z, Lam C, Hoffman J, et al. An evaluation of the initial treatment of acute asthma. Pediatrics. 1982;70:348–353
  10. Becker AB, Nelson NA, Simons FER. Inhaled salbutamol vs. injected epinephrine in the treatment of acute asthma in children. J Pediatr. 1983;102:465–469
  11. Louridas G, Kakoura M, Galanis N, et al. Bronchodilatory effect of inhaled versus oral salbutamol in bronchial asthma. Respiration. 1983;44:439–443
  12. Travers A, Jones AP, Kelly K, et al. Intravenous beta2-agonists for acute asthma in the emergency department. Cochrane Database Syst Rev. 2001;Art. No.: CD002988
  13. Putland M, Kerr D, Kelly AM. Adverse events associated with the use of intravenous epinephrine in emergency department patients presenting with severe asthma. Ann Emerg Med. 2006;47:559–563
  14. Plint AC, Osmond MH, Klassen TP. The efficacy of nebulized racemic epinephrine in children with acute asthma: a randomized, double-blind trial. Acad Emerg Med. 2000;7:1097–1103
  15. Nelson HS, Spector SL, Whitsett TL, et al. The bronchodilator response to inhalation of increasing doses of aerosolized albuterol. J Allergy Clin Immunol. 1983;72:371–375
  16. Schuh S, Parkin P, Rajan A, et al. High- versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics. 1989;83:513–518
  17. National Heart, Lung, and Blood Institute , National Institutes of Health . Expert panel report: guidelines for the diagnosis and management of asthma-update on selected topics 2002. 2003;NIH Publication No. 02-5074, Bethesda, MD
  18. Nelson HS, Bensch G, Pleskow WW, et al. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol. 1998;102:943–952
  19. Gawchik SM, Saccar CL, Noonan M, et al. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients. J Allergy Clin Immunol. 1999;103:615–621
  20. Carl JC, Myers TR, Kirchner HL, et al. Comparison of racemic albuterol and levalbuterol for treatment of acute asthma. J Pediatr. 2003;143:731–736
  21. Hardasmalani MD, DeBari V, Bithoney WG, et al. Levalbuterol versus racemic albuterol in the treatment of acute exacerbation of asthma in children. Pediatr Emerg Care. 2005;21:415–419
  22. Qureshi F, Zaritsky A, Welch C, et al. Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma. Ann Emerg Med. 2005;46:29–36
  23. Nowak R, Emerman C, Hanrahan JP, et al. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. Am J Emerg Med. 2006;24:259–267
  24. Abbott MB, Levin RH, Miller JA. Question from the clinician: levalbuterol in managing pediatric asthma. Pediatr Rev. 2002;23:401–403
  25. Plotnick LH, Ducharme FM. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev. 2000;Art. No.: CD000060
  26. Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with metaanalysis. Thorax. 2005;60:740–746
  27. Qureshi F, Zaritsky A, Lakkis H. Efficacy of nebulized ipratropium in severely asthmatic children. Ann Emerg Med. 1997;29:205–211
  28. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev. 2006;Art. No.: CD000052
  29. Chou KJ, Cunningham SJ, Crain EF. Metered-dose inhalers with spacers vs nebulizers for pediatric asthma. Arch Pediatr Adolesc Med. 1995;149:201–205
  30. Delgado A, Chou KJ, Silver EJ, et al. Nebulizers vs metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department. Arch Pediatr Adolesc Med. 2003;157:76–80
  31. Camargo CA, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists for acute asthma. Cochrane Database Syst Rev. 2003;Art. No.: CD001115
  32. Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005;127:335–371
  33. Deerojanawong J, Manuyakorn W, Prapphal N, et al. Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing. Pediatr Pulmonol. 2005;39:466–472
  34. Papo MC, Frank J, Thompson AE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med. 1993;21:1479–1486
  35. Khine H, Fuchs SM, Saville AL. Continuous vs intermittent nebulized albuterol for emergency management of asthma. Acad Emerg Med. 1996;3:1019–1024
  36. Frei SP. Cost comparison of bronchodilator delivery methods in emergency department treatment of asthma. J Emerg Med. 2000;19:323–326
  37. Leversha AM, Campanella SG, Aickin RP, et al. Costs and effectiveness of spacer versus nebulizer in young children with moderate and severe acute asthma. J Pediatr. 2000;136:497–502
  38. Linzer JF, Vance C, Letourneau M. Safety of continuously nebulized undiluted albuterol in children with severe acute asthma (abstract). Ped Emerg Care. 1996;12:328
  39. Rowe BH, Spooner C, Ducharme FM, et al. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev. 2001;Art. No.: CD002178
  40. Rowe BH, Spooner CH, Ducharme FM, et al. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev. 2001;Art. No.: CD000195
  41. Scarfone RJ, Fuchs SM, Nager AL, et al. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics. 1993;92:513–518
  42. Barnett PJL, Caputo GL, Baskin M, et al. Intravenous vs. oral corticosteroids in the management of acute asthma in children. Ann Emerg Med. 1997;29:212–217
  43. Becker JM, Arora A, Scarfone RJ, et al. Oral versus intravenous corticosteroids in children hospitalized with asthma. J Allergy Clin Immunol. 1999;103:586–590
  44. Klig JE, Hodge D, Rutherford MW. Symptomatic improvement following emergency department management of asthma: a pilot study of intramuscular dexamethasone versus oral prednisone. J Asthma. 1997;34:419–425
  45. Gries DM, Moffitt DR, Pulos E, et al. A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. J Pediatr. 2000;136:298–303
  46. Hendeles L. Selecting a systemic corticosteroid for acute asthma in young children. J Pediatr. 2003;142:S40–S44
  47. Storr J, Barrell E, Barry W, et al. Effect of a single oral dose of prednisolone in acute childhood asthma. Lancet. 1987;1:879–882
  48. Ellul-Micallef R, French FF. Effect of intravenous prednisolone in patients with diminished adrenergic responsiveness. Lancet. 1975;2:1269–1271
  49. McNamara RM, Rubin JM. Intramuscular methylprednisolone acetate for the prevention or relapse in acute asthma. Ann Emerg Med. 1993;22:1829–1835
  50. Lahn M, Bijur P, Gallagher EJ. Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest. 2004;126:362–368
  51. Qureshi F, Zaritsky A, Poirier MP. Comparative efficacy or oral dexamethasone versus oral prednisone in acute pediatric asthma. J Pediatr. 2001;139:20–26
  52. Sung L, Osmond MH, Klassen TP. Randomized, controlled trial of inhaled budesonide as an adjunct to oral prednisone in acute asthma. Acad Emerg Med. 1998;5:209–213
  53. Volovitz B. Inhaled budesonide in the management of acute worsenings and exacerbations of asthma: a review of the evidence. Respir Med. 2006;101:685–695
  54. Chipps BE, Chipps DR. A review of the role of inhaled corticosteroids in the treatment of acute asthma. Clin Pediatr. 2001;40:185–189
  55. Edmonds ML, Camargo CA, Pollack CV, et al. The effectiveness of inhaled corticosteroids in the emergency department treatment of acute asthma: a meta-analysis. Ann Emerg Med. 2002;40:145–154
  56. Tsai YG, Lee MY, Yang KD, et al. A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma. J Pediatr. 2001;139:433–437
  57. Devidayal , Singhi S, Kumar L, et al. Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma. Acta Paediatr. 1999;88:835–840
  58. Volovitz B, Bentur L, Finkelstein Y, et al. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J Allergy Clin Immunol. 1998;102:605–609
  59. Schuh S, Reisman J, Alshehri M, et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med. 2000;343:689–694
  60. Ververeli K, Chipps B. Oral corticosteroid–sparing effects of inhaled corticosteroids in the treatment of persistent and acute asthma. Ann Allergy Asthma Immun. 2004;92:512–522
  61. Singhi SC, Banerjee S, Nanjundaswamy HM. Inhaled budesonide in acute asthma. J Pediatr Child Health. 1999;35:483–487
  62. Nakanishi AK, Klasner AK, Rubin BK. A randomized control trial of inhaled flunisolide in the management of acute asthma in children. Chest. 2003;124:790–794
  63. Rodrigo G, Rodrigo C. Inhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med. 1998;157:698–703
  64. Spivey WH, Skobeloff EM, Levin RM. Effect of magnesium chloride on rabbit bronchial smooth muscle. Ann Emerg Med. 1990;19:1107–1112
  65. Lindeman KS, Hirshman CA, Freed AN. Effect of magnesium sulfate on bronchoconstriction in the lung periphery. J Appl Physiol. 1989;66:2527–2532
  66. Rowe BH, Bretzlaff JA, Bourdon C, et al. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev. 2000;Art. No.: CD001490
  67. Blitz M, Blitz S, Beasely R, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2005;Art. No.: CD003898
  68. Ciarallo L, Brousseau D, Reinert S. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma. Arch Pediatr Adolesc Med. 2000;154:979–983
  69. Blitz M, Blitz S, Hughes R, et al. Aerosolized magnesium sulfate for acute asthma: a systematic review. Chest. 2005;128:337–344
  70. Shirk MB, Donahue KR, Shirvani J. Unlabeled uses of nebulized medications. Am J Health Syst Pharm. 2006;63:1704–1716
  71. Mahajan P, Haritos D, Rosenberg N, et al. Comparison of nebulized magnesium plus albuterol to nebulized albuterol plus saline in children with mild to moderate asthma. J Emerg Med. 2004;27:21–25
  72. Papamoschou D. Theoretical validation of the respiratory benefits of helium-oxygen mixtures. Respir Physiol. 1995;99:183–190
  73. Anderson M, Svartengren M, Bylin G, et al. Deposition in asthmatics of particles inhaled in air or in helium-oxygen. Am Rev Respir Dis. 1993;147:524–528
  74. Hess DR, Acosta FI, Ritz RH, et al. The effect of heliox on nebulizer function using a beta-agonist bronchodilator. Chest. 1999;115:184–189
  75. Rodrigo G, Pollack C, Rodrigo C, et al. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev. 2006;Art. No.: CD002884
  76. Kim IK, Phrampus E, Venkataraman S, et al. Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. Pediatrics. 2005;116:1127–1133
  77. Kudukis TM, Manthous CA, Schmidt GA, et al. Inhaled helium-oxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children. J Pediatr. 1997;130:217–224
  78. Sarma VJ. Use of ketamine in acute severe asthma. Acta Anaesthesiol Scand. 1992;36:106–107
  79. Strube PJ, Hallam PL. Ketamine by continuous infusion in status asthmaticus. Anaesthesia. 1986;40:1017–1019
  80. Howton JC, Rose J, Duffy S, et al. Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma. Ann Emerg Med. 1996;27:170–175
  81. Denmark TK, Crane HA, Brown L. Ketamine to avoid mechanical ventilation in severe pediatric asthma. J Emerg Med. 2006;30:163–166
  82. Petrillo TM, Fortenberry JD, Linzer JF, et al. Emergency department use of ketamine in pediatric status asthmaticus. J Asthma. 2001;38:657–664
  83. Allen JY, Macias CG. The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. Ann Emerg Med. 2005;46:43–50
  84. Mitra A, Bassler D, Watts K, et al. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. Cochrane Database Syst Rev. 2005;Art. No.: CD001276
  85. Harmanci K, Bakirtas A, Turktas I, et al. Oral montelukast treatment of preschool-aged children with acute asthma. Ann Allergy Asthma Immunol. 2006;96:731–735
  86. Silverman RA, Nowak RM, Korenblat PE, et al. Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial. Chest. 2004;126:1480–1489
  87. Fortenberry JD, Del Toro J, Jefferson LS, et al. Management of pediatric acute hypoxemic respiratory insufficiency with bilevel positive pressure (BiPAP) nasal mask ventilation. Chest. 1995;108:1059–1064
  88. Ram FSF, Wellington SR, Rowe B, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev. 2005;Art. No.: CD004360
  89. Beers SL, Abramo TJ, Bracken A, et al. Bilevel positive airway pressure in the treatment of status asthmaticus in pediatrics. Am J Emerg Med. 2007;25:6–9
  90. Graham V, Lasserson TJ, Rowe BH. Antibiotics for acute asthma. Cochrane Database Syst Rev. 2001;Art. No.: CD002741
  91. Boychuk RB, Yamamoto LG, DeMesa CJ, et al. Correlation of initial emergency department pulse oximetry values in asthma severity classes (steps) with the risk of hospitalization. Am J Emerg Med. 2006;24:48–52
  92. Rowe BH, Bota GW, Fabris L, et al. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial. JAMA. 1999;281:2119–2126
  93. Sin DD, Man SF. Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch Intern Med. 2002;162:1591–1595

PII: S1522-8401(07)00024-9

doi: 10.1016/j.cpem.2007.04.003

Clinical Pediatric Emergency Medicine
Volume 8, Issue 2 , Pages 87-95 , June 2007

Article Tools

* Image Usage & Resolution